Table 5 Comparison of patients with cancer with and without metastasis.

From: Comparison of surgical outcomes for hip fracture between older patients with and without cancer: a propensity score matching analysis

 

Metastasis ( +) (n = 54)

Metastasis (−) (n = 219)

P-value

Operative time, min (SD)

62.3 (26.8)

60.6 (27.0)

0.667

Transfusion profile

   

 Preoperative transfusion, n (%)

14 (25.9)

37 (16.9)

0.171

 Intraoperative transfusion, n (%)

8 (14.8)

20 (9.1)

0.315

 Postoperative transfusion, n (%)

23 (42.6)

99 (45.2)

0.762

 Total volume of perioperative transfusion, pack (range)

2.2 (3.5)

2.0 (4.3)

0.706

Complications, n (%)

 Pneumonia

5 (9.3)

20 (9.1)

1.000

 DVT

1 (0.8)

3 (1.4)

1.000

 PTE

0 (0)

1 (0.5)

1.000

 MI/Angina

2 (3.7)

4 (1.8)

0.339

 UTI

0 (0)

9 (4.1)

0.212

 Acute PJI

1 (1.9)

3 (1.4)

1.000

Rate of reoperation due to any cause, n (%)

1 (1.9)

7 (3.2)

1.000

Hospital stay, days (SD)

14.8 (13.6)

12.9 (11.2)

0.290

ICU admission, n (%)

9 (16.7)

38 (17.4)

1.000

Mortality rate, n (%)

 Death during the admission period

1 (1.9)

4 (1.8)

1.000

 30-day mortality

3 (5.8)

5 (2.4)

0.199

 1-year mortality

21 (55.3)

26 (16.5)

 < 0.001

  1. DVT; deep vein thrombosis; ICU, intensive care unit; IQR, interquartile range; mHHS; modified Harris hip score; MI; myocardial infarction; Op., operation; PJI, prosthetic joint infection; PS, propensity score; PTE, pulmonary thromboembolism; SD, standard deviation; UTI, urinary tract infection.
  2. Significant values are in [bold].